ReferencesAnderson, I. Jan 8, 1994. Powdered milk cure for fatal diarrhea. New Scientist, pp.6 Benjamini, E., Sunshine, G., and Leskowitz, S., 1996. Immunology A Short Course, Third Edition, Wiley-Liss, New York, pgs.19-30 Boersma, ER; Offringa PJ; Muskiet FA; Chase WM; Simmons IJ Vitamin E, lipid fractions, and fatty acid composition of colostrum, transitional milk, and mature milk: an international comprehensive study. Am J Clin Nutr 1991 May;53(5):1197-204 Brines RD, Broch JH, 1983. The effect of trypsin and chymotrypsin on the in-vitro antimicrobial and iron-binding properties of lactoferrin in human milk and bovine colostrum. Unusual resistence of human apolactorferrin to proteolytic digestion. Biochim Biophys Acta, 759: 229-35 Buchta, R., Ovine lactoferrin: isolation from colostrum and characterization. J Dairy Res 1991 May; 58(2):221-8 Buescher, ES and McIlheran, 1998. Antioxident Properties of Human Colostrum. Pediatric Research, 24(1):14-9 Burrin, Douglas G. et al., 1996. Orally Administered Lactoferrin Increases Hepatic Protein Synthesis in Formula-Fed Newborn Pigs. Pediatric Research, 40(1):72-76 Casswell TH, Sarker SA, Albert MJ, et al., 1998. Treatment of Helicobacter pylori infection in infants in rural Bangledesh with oral immunoglobulins from hyperimmune bovine colostrum. Aliment Pharmacol Ther, 12:563-8 Davidson, GP. et al., Sept 23, 1989. Passive Immunization of Children with Bovine Colostrum Containing Antibodies to Human Rotavirum. The Lancet, 709-712 Aoki, T., Kaneko, Y. Stefanski, M.S., Nguyen, T., and Ting, R.C.Y. 1991. Curdlan sulfate and HIV-1 infection. In AIDS Research and Human Retroviruses, Vol. 7, No. 4, 409-415. Mary Ann , Liebert, Inc. Publishers. Behall, K.M., Scholfield, D.J. and Hallfrisch, J. 1997. Effect of b-Glucan level in oat fiber extracts on blood lipids in men and women. Journal of the American College of Nutrition, Vol. 16, No. 1, 46-51. Birt, D.F., Pelling, J.C., White, L.T., Dimitroff, K., and Barnett, T. 1991. Influence of diet and calorie restriction on the initiation and promotion of skin carcinogenesis in the Sencar mouse model. Cancer Research, 51:1851-1854 Di Luzio, N.R. 1983. Immunopharmacology of Glucan: a broad spectrum enhancer of host defense mechanisms. In TIPS, Elsevier Science Publishers B.V., Amsterdam, pp. 344-347 Harada, T., Sato, S., and Harada, A. 1987. Curdlan, Bulletin of Kobe WomenÕs University, Vol. 20-2,pp. 142-164 Klurfeld, D.M., 1992. Dietary fiber-mediated mechanisms in carcinogenesis. Cancer Research, 52:2055s-2059s. Livesey, G. 1990. Energy values of unavailable carbohydrates and diets: An inquiry and analysis. American Journal of Clinical Nutrition, 51:617-637 Madar, Z., and Odes, H.S. 1990. Dietary fiber in metabolic diseases. In Dietary Fiber Research, R. Paoletti, ed., pp. 90-96. Basel:Krager. Sasaki, T., Abiko, N., Nitta, K., Takasuka, N., and Sugino, Y. 1979. Antitumor activity of carboxymethlglucans obtained by carboxymethylation of (1,3)-b-D-Glucan from Alcaligenes faecalis var. myxogenes IFO 13140. European Journal of Cancer, Vol. 16, pp.221-215 Wood, P.J., Braaten, J.T., Scott F.W., Riedel, K.D., Wloynetz, M.S. and Collings, M.W., ÒEffect of Dose and Modification of Viscous Properties of Oat Gum on Blood Glucose and Insulin Following and Oral Glucose LoadÓ, British Journal of Nutrition, 72-731-743, 1994. Hauer J, Anderer, F.A. Mechanism of stimulation of human natural killer cells by arabinogalactan from Lanx occidentalis. Cancer Immunol 36(4):237-44 Kind, L.S., Nilsson, B. The biological activity of a ragweed arabinogalactan. Lactose specificty of in vitro and in vivo effects. Immunology (1967 Nov) 13(5):4 Hagmar, B., Ryd, W., Skomedal, H. Arbinogalactan blockade of experimental metastases to liver by immune hepatoma. Invasion Metastasis (1991) 11(6):348-55 Beuth, J., Ko, H.L., Oette, K., Pulverer G., Roszkowski, K., Uhlenbruck, G. Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose. J Cancer Res Clin Oncol (1987) 113(1):51-5 Beuth, J., Ko, H.L., Schirmacher, V., Uhlenbruck, G. Pulverer G. Inhibition of liver tumor cell colonization in two animal tumor models by lectin blocking with D-galactose or arabinogalactan. Clin Exp Metastasis (1988 Mar-Apr) 6(2):115-20 Hagiwera, T. et al. Effects of lactoferrin and its peptides on proliferation of rat intestinal epitjelial cell line IEC-18 in the presence of EGF. Biosci. Biotech. Biochem. 59:1875 (1995). Oguchi, S. et al. Iron saturation alters the effect of lactoferrin on the proliferation and differentiation of human enterocytes. Biol. Neonate 67:330 (1995). Petschow, B. et al. Response of Bifidobacteria species to growth promoters in human and cow milk. Pediatric Res. 29:208 (1991). Oram, J.D. and Reiter, B. Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochem. Biophys. Acta. 170:351 (1968). Bellamy, W. et al. Antibacterial spectrum of lactoferrin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 73:472 (1992). Ellison, R.T. et al. Damage of the outer member of enteric Gram negative bacteria by lactoferrin and transferrin. Infect. and Immu. 56:2274 (1998) Reiter, B. The biological significance of the non-immunoglobulin protective proteins in milk. In:Developments in Dairy Chemistry-Vol 3;pp281-336 (1985) Nagasako, Y. et al. Iron building properties of bovine lactoferrin in iron rich solutions. J. Dairy Sci. 76:1876 (1993 Ward, P. et al. Cooperative interactions between amino- and carboxyl-terminal lobes contribute to the unique iron-binding stability of lactoferrin. J. Biol. Chem. 271:12790 (1996). Cox, T. et al. Iron-binding proteins and influx of iron across the duodenal brushboarder. Evidence for specific lactotransferrin receptors in the human intestine. Biochem. Biophys. Acta. 558:120 (1979) Gutteridge, J.M. et al. Inhibitor of lipid peroxidation by the iron-binding protein lactoferrin. Biochem J. 199:259-261 (1991) Gahi, M. et al. Influence of lactoferrin on the funtion of human polymorphonuclear leukocytes and monocytes. J. Leukoc. Biol. 49:427 (1991) Shau, H. et al. Modulation of naturla killer and lymphokine-activcated killer cell cytotoxcity by lactoferrin. J. Leukoc Biol. 51:343 (1992) Shinoda, I. et al. Effects of lactoferrin and lactoferrin on release of Interleukin 8 from human polymorphonuclear leukocytes. Biosci. Biochem. 60(3):526 (1996). |